At 6.4% CAGR, Asia Pacific Balloon Aortic Valvuloplasty Market is Projected to be Worth US$ 69.16 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the Asia Pacific balloon aortic valvuloplasty market was valued at US$ 42.05 million in 2023 and is expected to reach US$ 69.16 million by 2031, registering a CAGR of 6.4% from 2023 to 2031. Increasing demand for minimally invasive procedures and rising prevalence of aortic valve stenosis are among the critical factors attributed to drive the Asia Pacific balloon aortic valvuloplasty market growth.

The soaring demand for minimally invasive techniques in valve replacement surgeries reflects a significant shift in medical practices and patient preferences. In a minimally invasive aortic valvuloplasty, the aortic valve of the heart is repaired and, if needed, is also replaced through TAVI procedures. Minimally invasive techniques are driven by the desire to reduce the invasiveness of procedures, minimize the associated risks, and promote faster recovery times. Minimally invasive approaches usually involve smaller incisions with the use of specialized instruments and technologies to access the heart, which can lead to shorter hospital stays and less scarring. Additionally, patients often experience less pain and a faster return to their daily activities.

All branches of medicine, including cardiology, are witnessing an increase in the demand for less invasive procedures because of several benefits over traditional open-heart surgery. Compared to open-heart surgery, patients who undergo minimally invasive procedures usually have a shorter recovery time. In addition, minimally invasive techniques have a lower risk of complications and result in fewer scars compared to open cardiac surgery. Surgeons have adopted these techniques due to advancements in medical devices, and improved surgical skills can further facilitate widespread adoption. As BAV is a minimally invasive technique that can be used to treat a variety of heart problems, including aortic valve stenosis, the market for BAV devices is being driven by the increased demand for minimally invasive procedures. As a result, healthcare organizations are investing in training their medical teams and obtaining the necessary equipment to meet the growing demand for minimally invasive BAV and TAVI surgeries, thereby providing patients with enhanced treatment options and better overall healthcare experiences. Thus, the balloon aortic valvuloplasty market witnesses notable growth.

On the contrary, high cost of procedures hampers the growth of Asia Pacific balloon aortic valvuloplasty market.

Based on product type, the Asia Pacific balloon aortic valvuloplasty market is segmented into non compliant balloons and semi compliant balloons. The non compliant balloons segment held 71.5% market share in 2023, amassing US$ 30.04 million. It is projected to garner US$ 50.75 million by 2031 to register 6.8% CAGR during 2023-2031.

By country, the Asia Pacific balloon aortic valvuloplasty market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 28.9% share of Asia Pacific balloon aortic valvuloplasty market in 2023. It was assessed at US$ 12.13 million in 2023 and is likely to hit US$ 20.62 million by 2031, registering a CAGR of 6.9% during 2023-2031.

Key players operating in the Asia Pacific balloon aortic valvuloplasty market B Braun SE; TT Medical, Inc.; Balton; Becton Dickinson and Co; Edwards Lifesciences Corp; Balt; Venus MedTech HangZhou Inc; and OSYPKA, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com